Lund, Sweden, 10 June 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander. Read more… The post Hansa Biopharma appoints Fredrik Röök as VP Business Development appeared first on Optimum Strategic Communications.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.